Platform
Features
1 follower
Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way.
Industries
Headquarters
Employees
Links
Stephen S. Yoder
20 members
6 members
Rimsys
Biotrial Inc.
Astria Therapeutics
Bristol-Myers Squibb
168 followers
Omnicell
20 followers
Catalent
15 followers
NYU Langone Health
12 followers
Nektar Therapeutics
7 followers
PCI Pharma Services
6 followers
Parexel
Amarin
5 followers
Discover companies